Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | STAT1 | P42224 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.47 |
| ▸ | SOD1 | P00441 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29893927 | 0.98 | ACHE (0.50) | ACHECYP3A4LMNAHTTNPC1 | |
| SCHEMBL13009187 | 0.92 | SMN1; SMN2 (0.55) | ACHECYP3A4LMNAHTTNPC1 | |
| SCHEMBL16663957 | 0.88 | KIF11 (0.55) | ACHECYP3A4LMNAHTTNPC1 | |
| Phenol SCHEMBL28262366 | 0.87 | KIF11 (0.47) | ACHECYP3A4LMNAHTTNPC1 | |
| SCHEMBL8408204 | 0.86 | ACHE (0.52) | ACHECYP3A4LMNAHTTNPC1 | |
| SCHEMBL278328 | 0.86 | LTA4H (0.55) | CYP3A4LMNAHTTNPC1MAPT | |
| SCHEMBL19326347 | 0.84 | SOD1 (0.47) | ACHECYP3A4LMNAHTTNPC1 | |
| SCHEMBL18118971 | 0.84 | CYP3A4 (0.59) | ACHECYP3A4LMNAHTTNPC1 | |
| SCHEMBL28407343 | 0.84 | CYP3A4 (0.50) | ACHECYP3A4LMNAHTTNPC1 | |
| SCHEMBL13439849 | 0.83 | MAOB (0.61) | NPC1RAB9ASOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114317448-A | Hybridoma cell strain secreting anti-etoxazole monoclonal antibody and application thereof | 无锡迪腾敏生物科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| WO-2020210428-A1 | NOVEL INHIBITORS OF FLAVIVIRUS PROTEASE FOR PREVENTION AND TREATMENT OF ZIKA, DENGUE AND OTHER FLAVIVIRUS INFECTIONS | BAYLOR COLLEGE OF MEDICINE (US) | 2020-10-15 | — | — | WO | claimed |
| US-8426115-B2 | Patterning process and resist composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-04-23 | — | — | US | claimed |
| US-20110033803-A1 | PATTERNING PROCESS AND RESIST COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-02-10 | — | — | US | claimed |
| EP-1733450-B1 | REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES CO (US) | 2010-12-08 | — | — | EP | claimed |
| US-7811710-B2 | Redox shuttle for rechargeable lithium-ion cell | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-10-12 | — | — | US | claimed |
| US-20100159392-A1 | PATTERNING PROCESS AND RESIST COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-06-24 | — | — | US | claimed |
| EP-1733450-A2 | REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL | 3M Innovative Properties Company (US) | 2006-12-20 | — | — | EP | claimed |
| WO-2005099024-A2 | REDOX SHUTTLE FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-10-20 | — | — | WO | claimed |
| US-20050221196-A1 | Redox shuttle for rechargeable lithium-ion cell | 3M INNOVATIVE PROPERTIES COMPANY | 2005-10-06 | — | — | US | claimed |
| EP-4680226-A2 | ACYLSULFONAMIDE KAT6A INHIBITORS | Olema Pharmaceuticals, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20260015327-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | OLEMA PHARMACEUTICALS INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12428379-B2 | Acylsulfonamide KAT6A inhibitors | OLEMA PHARMACEUTICALS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250136553-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | OLEMA PHARMACEUTICALS, INC. | 2025-05-01 | — | — | US | disclosed |
| US-20250059204-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | AURIGENE ONCOLOGY LIMITED (IN) | 2025-02-20 | — | — | US | disclosed |
| WO-1998040339-A1 | METHOD FOR ACYLATION OR SULPHONATION OF AN AROMATIC COMPOUND | RHODIA CHIMIE (FR) | 1998-09-17 | — | — | WO | disclosed |
| US-5637773-A | FORMING HYDROXY-AND/OR ALKOXYAROMATIC ALKYLKETONES | RHONE-POULENC CHIMIE (FR) | 1997-06-10 | — | — | US | disclosed |
| EP-0698593-A1 | Process for the acylation of an aromatic compound | RHONE-POULENC CHIMIE (FR) | 1996-02-28 | — | — | EP | disclosed |
| US-4837301-A | FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | disclosed |
| EP-0275007-A2 | Process for the preparation of highly molecular, optionally branched polyarylene sulfides | BAYER AG (DE) | 1988-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136553-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | KAT6A, KAT2A, KAT6B | ACHE 3810/4885CYP3A4 4298/4885LMNA 4112/4885 |
| US-12428379-B2 | Acylsulfonamide KAT6A inhibitors | KAT6A, KAT2A, KAT6B | ACHE 3810/4885CYP3A4 4298/4885LMNA 4112/4885 |
| US-20260015327-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | KAT6A, KAT2A, KAT6B | ACHE 3897/4885CYP3A4 3304/4885LMNA 3385/4885 |
| US-20250059204-A1 | FUSED BENZOISOXAZOLYL COMPOUNDS AS KAT6A INHIBITORS | KAT6A, KAT2A, KAT6B | ACHE 3547/4885CYP3A4 3135/4885LMNA 3609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.